Newsroom
Sorted by: Latest
-
Cleveland Diagnostics Appoints Valerie Dixon as Chief Financial Officer
CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics Appoints Valerie Dixon as Chief Financial Officer...
-
Soluna and Bitdeer Enter 28 MW Agreement at Project Kati 1
ALBANY, N.Y.--(BUSINESS WIRE)--Soluna Holdings, Inc. ("Soluna" or the "Company") (NASDAQ: SLNH), a developer of green data centers for intensive computing applications, including AI and Bitcoin mining, today announced that one of its subsidiaries has entered into an agreement with Dory Creek, LLC, a wholly owned subsidiary of Bitdeer Technologies Group ("Bitdeer") (NASDAQ: BTDR), a world-leading technology company for AI and Bitcoin mining infrastructure. Under the agreement, Bitdeer will deplo...
-
The Marzetti Company Reports Fourth Quarter and Fiscal Year Results
WESTERVILLE, Ohio--(BUSINESS WIRE)--The Marzetti Company (Nasdaq: MZTI) reported results today for the company’s fiscal fourth quarter and fiscal year ended June 30, 2026. Fourth Quarter Summary Consolidated fourth quarter net sales declined 2.2% to $465.0 million. Excluding the prior-year quarter’s $12.2 million in non-core sales attributed to a temporary supply agreement (“TSA”) with Winland Foods, Inc., which concluded during the quarter ended March 31, 2026, consolidated net sales increased...
-
Six Flags to Relocate Corporate Headquarters to Arlington, Texas, Strengthening North American Operations
CHARLOTTE, N.C.--(BUSINESS WIRE)--Six Flags announces plans to move its corporate headquarters in 2027 from Charlotte, North Carolina to Arlington, Texas....
-
Pretzel Therapeutics Advances PX578 into Phase 2 Study in Individuals Living with POLG-mediated Primary Mitochondrial Disease Following FDA Clearance of IND
WALTHAM, Mass.--(BUSINESS WIRE)--Pretzel Therapeutics, Inc., a clinical-stage biotechnology company advancing a new class of medicines designed to restore mitochondrial function, improve cellular energetics and impede disease progression across a range of neurological and rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to initiate a first-in-patient clinical trial of PX578, the Company’s lead therapeutic...
-
KBRA Releases Research – UK Buy-to-Let RMBS: Stabilising Credit, Broadening Issuance
LONDON--(BUSINESS WIRE)--KBRA releases research examining recent trends in the UK buy-to-let (BTL) market, including issuance and credit performance, as well as how tenancy reform and planned energy efficiency requirements could affect the sector over time. The BTL market has benefited from a more favourable interest rate environment, with lower borrowing costs and continued rental growth supporting landlord cash flow, interest coverage, and remortgaging capacity. Arrears among pre-2014 loans h...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Low Duration Global Government Bond UCITS ETF 24.08.2026 FGOV LN IE00BKS2X200 83,638.00 GBP 1,241,988.86 17.355 ...
-
Fasset تتجاوز تقييمًا قدره مليار دولار بعد أن قادت SBI Group جولة تمويل من السلسلة C بقيمة 68 مليون دولار، بهدف توسيع نطاق خدماتها المصرفية الرقمية القائمة على الذكاء الاصطناعي والعملات المستقرة
لوس أنجلوس--(BUSINESS WIRE)--أعلنت Fasset، منصة الخدمات المصرفية الرقمية القائمة على العملات المستقرة والمدعومة بالذكاء الاصطناعي، اليوم عن جمع 68 مليون دولار في جولة تمويل من السلسلة C، رافعةً تقييمها إلى مليار دولار. قادت SBI Group جولة التمويل، التي تأتي عقب جولة التمويل من السلسلة B التي جمعت خلالها Fasset مبلغ 51 مليون دولار في وقت سابق من هذا العام، والتي انضمت فيها Speedinvest إلى قائمة المساهمين إلى جانب مجموعة من المستثمرين الاستراتيجيين.يتناول هذا البيان الصحفي الوسائط المتعددة. يمكنك...
-
Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit
SAN DIEGO--(BUSINESS WIRE)--The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Aardvark Therapeutics, Inc. (NASDAQ: AARD) shares in the U.S. District Court for the Southern District of California (No: 3:26-cv-04643). Investors, who purchased a significant amount of Aardvark Therapeutics, Inc. (NASDAQ: AARD) between February 13, 2025 and May 14, 2026, in excess of $100,000 have certain options and there are short and strict deadlines running. Deadline:...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust IPOX Europe Equity Opportunities UCITS ETF 24.08.2026 IPXE.IM IE00BFD26097 50,002.00 EUR 1,243,225.38 24.864 ...